EC
BDSI

Engaged Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Engaged Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-188,750
Closed -$330K – 18
2016
Q4 		$330K Sell
188,750
-1,687,800
-90% -$3.45M 0.11% 14
2016
Q3 		$5.07M Hold
1,876,550
– – 1.84% 10
2016
Q2 		$4.43M Hold
1,876,550
– – 1.56% 10
2016
Q1 		$6.06M Buy
+1,876,550
New +$6.93M 2.05% 10

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Engaged Capital's BDSI Position: Q1 2017 in Review

Engaged Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 188,750 shares — an estimated $330K sold.

Engaged Capital first reported a position in BDSI in Q1 2016 and held it in 4 quarters. The position peaked at $6.06M in Q1 2016. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

  • Engaged Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
  • Engaged Capital sold 188,750 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $330K.
  • Engaged Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 4 quarters.
  • Engaged Capital's BioDelivery Sciences International, Inc. position peaked at $6.06M in Q1 2016.
  • 63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on Engaged Capital's 13F filing for Q1 2017, filed 15 May 2017.